Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.
about
Regulation of EPCs: The Gateway to Blood Vessel FormationThe endothelium abridges insulin resistance to premature agingAmbient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cellsEndothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseFunctional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological MalignanciesCirculating Vascular Progenitor Cells in Moyamoya DiseaseConcise review: therapeutic potential of adipose tissue-derived angiogenic cellsReactive oxygen species adversely impacts bone marrow microenvironment in diabetesIntroduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicineCharacterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier ModelingEndothelial progenitor cells and burn injury - exploring the relationshipVascular diseases await translation of blood vessels engineered from stem cellsEpigenetic regulation of endothelial-cell-mediated vascular repairCirculating and tissue resident endothelial progenitor cellsInsulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasisEffects of TiO₂ and Co₃O₄ nanoparticles on circulating angiogenic cellsInnovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction.Lung function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II.[Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Mobilization of CD34+-progenitor cells in patients with severe trauma.Emerging role of exosome-mediated intercellular communication in vascular remodelingThe dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsEndothelial progenitor cells: therapeutic perspective for ischemic stroke.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Decreased level of cord blood circulating endothelial colony-forming cells in preeclampsiaCirculating autoantibodies to endothelial progenitor cells: binding characteristics and association with risk factors for atherosclerosisIs chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapyMdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice.Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice.Circulating hematopoietic progenitor cells are decreased in COPD.Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.An affordable method to obtain cultured endothelial cells from peripheral blood.Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells.Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses.Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns.Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation.Differential regulation of bone marrow-derived endothelial progenitor cells and endothelial outgrowth cells by the Notch signaling pathway
P2860
Q21284530-4A63EDAD-49A1-4C8D-A976-95F6B3895547Q24605364-228BB5A2-50F1-42DD-A4C9-87A97A8354F1Q26764744-0F118FA9-6E96-4B4A-A917-95A7EEF47E05Q26770056-0FFA38A2-0829-4A84-9CCA-D46C1F9D64ACQ26770838-45DD345A-ACB1-4E4D-8BF9-0FF025EA0DBBQ26800758-62E07BA8-96B6-4170-A9C3-E0B498D7FB23Q26998587-BC2E6B38-ABCA-43FD-9374-879DA6DE9D79Q27002524-9F570440-7484-4B85-903F-A19A4C4D5E03Q27027618-FB195121-0E0D-4720-8801-5749EE420F42Q27315171-59A31508-55F3-4317-A417-AD1675DE791AQ28072654-02027BCC-D8B1-4536-ADA3-6D283EFBCB50Q28078941-78D1FBFA-70DB-4BB1-B59B-25D32669E80AQ28083072-CC14ADDF-532C-4A71-A0FB-BBE47CD2B78BQ28085420-C9342B56-D338-4E69-96CE-96097853FEC7Q28293322-A9BAA998-5965-4070-8E4D-B562B5BC070AQ28385776-0B75C5C5-DF0E-4C3F-91F2-6FC1158F9063Q28390439-5877B401-9ED0-4FFA-8D1C-136005FFBBFFQ30374603-1B8ED33E-B50B-49CC-8CCA-DE4F870E94FFQ31012073-81D1D0F3-C5C6-48AE-B63C-F55061F82B48Q31012080-F50DF1A6-C663-4658-BB1B-5AA6DC846A97Q33562214-84E2EDB5-D7A8-4D71-83C4-AF6FC21C61DAQ33610314-961FBBF9-A67C-4B0E-89F5-0C18CF304EF7Q33649005-74C4860B-2031-496E-9F93-4987C6FC659AQ33662677-DBD0A99E-FD5A-4771-BCF3-DB38160BCAB3Q33705402-94231A22-54DA-48F8-BD89-CB7AE103F36BQ33745962-EF615105-B4E7-4BD2-A7B1-38FBDA658930Q33754034-41E7C410-A8E3-406F-B1D3-D06FE77A52FDQ33778787-B817B2B0-9FE9-4545-B7A6-6A0AE09C7AC6Q33783109-C0F8C067-DCCE-4B70-8BF4-86F741743353Q33793376-22D06F3C-CEC8-45A3-AC8A-3082E9E7B7EAQ33800230-819C7D8C-F9F3-4322-9C83-D92937CFE844Q33861718-01EBD624-B960-4194-BF8C-3D9DC7416DA5Q33954480-FD8AAC6A-A135-4304-838B-86C4D0398A6BQ33975637-4276A849-79B7-40C5-A85E-4AAD89AABF01Q33982368-B73660AF-F091-40C0-AEF4-C529A8D87278Q34105446-7B308FD3-1453-4AE3-8A94-C192CF92B180Q34361728-939A5A03-20A4-4629-BBE4-3D8B4DB65487Q34416752-28C49B0C-D5F3-4B5F-A5F7-9DB2D32E8EF3Q34446306-27D1F134-BB0B-4514-BE7D-BD75D2BF4427Q34464364-4048D3CE-2C0A-4911-88BC-8E13B05E99DB
P2860
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@ast
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@en
type
label
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@ast
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@en
prefLabel
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@ast
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@en
P2860
P1433
P1476
Critical reevaluation of endot ...... herapeutic and diagnostic use.
@en
P2093
Douglas Losordo
P2860
P304
P356
10.1161/CIRCRESAHA.111.243386
P577
2012-02-01T00:00:00Z